Old Well Partners’s Vor Biopharma VOR Stock Holding History

Old Well Partners’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-234	Closed	-$202K	–	47
2021 Q1	$202K	Buy	+234	New	+$198K	0.1%	37

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Old Well Partners's VOR Position: Q2 2021 in Review

Old Well Partners sold out of Vor Biopharma (VOR) in Q2 2021, closing a stake of 234 shares — an estimated $202K sold.

Old Well Partners first reported a position in VOR in Q1 2021 and held it in 1 quarter. The position peaked at $202K in Q1 2021. 51 funds tracked by Wall St. Rank hold VOR as of Q2 2021.

Old Well Partners reported no remaining Vor Biopharma position as of Q2 2021 after selling out during the quarter.
Old Well Partners sold 234 Vor Biopharma shares in Q2 2021, an estimated $202K.
Old Well Partners first reported a position in Vor Biopharma in Q1 2021 and held it in 1 quarter.
Old Well Partners's Vor Biopharma position peaked at $202K in Q1 2021.
51 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2021.

Based on Old Well Partners's 13F filing for Q2 2021, filed 16 Aug 2021.